ENGN

enGene Therapeutics Inc. $1.53 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.9%
Next 1 week
+4.4%
Next 1 month
+4.9%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 23
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.31%/day.
Mean-reversion stats →
1-month breakdown — Market · β 2.04 +4.9% · Seasonal tilt (3y) -0.0%
$1M/day volume 117% volatility -79% 1-year
52-week range · 1% of the way up · -88% from the high
$1.40$12.25

Earnings Full history →

Next report 2026-12-22 (Tuesday, before open, in 50 days) · EPS est. -0.46.

1-day std dev
8.0%
Finished up
55%
Biggest pop
+9.3%
Biggest drop
-18.8%

Standard deviation of the close-to-close move over the last 11 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-09-08 miss -0.43 -0.47 -9.9% +0.0% +5.5% +3.8%
2026-06-15 beat -0.47 -0.43 +8.6% +8.0% +9.3% +5.6%
2026-03-09 beat -0.57 -0.44 +23.3% -7.1% -18.8% -16.7%
2025-12-22 miss -0.58 -0.73 -26.2% +0.0% +5.1% +3.0%
2025-09-11 miss -0.51 -0.57 -12.1% +0.0% -5.8% +12.5%
2025-06-12 miss -0.48 -0.51 -6.2% +4.3% +0.9% -2.2%
2025-03-10 miss -0.37 -0.48 -29.1% +2.1% -1.7% -1.7%
2024-12-19 beat -0.36 -0.34 +6.1% +9.7% -2.2% +13.3%
2024-09-10 beat -0.35 -0.32 +8.1% -1.2% +3.1% +11.8%
2024-06-14 miss -0.27 -0.38 -41.4% +5.7% -10.0% -18.7%
2024-03-11 beat -0.47 -0.46 +2.1% -0.8% +1.6% +8.9%

Not investment advice.